ArticleLung India : official organ of Indian Chest Society2026
Short-term outcome of veno-venous extracorporeal membrane oxygenation in patients of acute respiratory distress syndrome presenting at a tertiary care centre - An observational study.
Article in Lung India : official organ of Indian Chest Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Overfitting and subgroup P -value inconsistencies in mortality prediction analysis of a VV-ECMO cohort.Lung India : official organ of Indian Chest Society · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectiveAcute respiratory distress syndrome (ARDS) is a severe and potentially fatal condition characterised by inflammation and damage to the lungs. Veno-venous (VV) extracorporeal membrane oxygenation (ECMO) is a form of life support that can be used in the management of ARDS. This study was done to evaluate the short-term outcome of VV ECMO in patients of ARDS presenting at our institute. MATERIALS: This ambispective observational study was carried out on patients with severe ARDS on VV ECMO admitted to the intensive care unit (ICU). Parameters studied included duration of pre-ECMO and total duration of mechanical ventilation, duration of ECMO, length of stay in ICU, length of hospital stay, and in-hospital mortality from the case records. The APACHE II, SOFA, and Murray scores were also recorded.
resultsThe mean age of the ARDS patients in our study was 48.70 ± 12.06 years. Out of 70 study patients, 41 were male and 29 were female. The most common underlying causes of ARDS requiring VV ECMO were pneumonia and sepsis. The primary indication for ECMO initiation in all patients was refractory hypoxemia despite optimal conventional ventilation. The rate of mortality was significantly higher in patients with pneumonia (44.7%) and sepsis (44.4%). The mean duration of mechanical ventilation and the mean duration of ECMO were 21.86 ± 13.19 days and 16.35 ± 10.11 days, respectively. The mean duration of ICU and hospital stay in our study was 23.26 ± 12.25 days and 27.33 ± 14.44 days, respectively. The proportion of survivors (58.6%) was higher than that of non-survivors (41.4%).
conclusionVV ECMO can be used as a treatment option for patients with severe ARDS who are failing conventional mechanical ventilation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.